<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2020-65-3-131-137</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДИСКУССИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DISCUSSIN</subject></subj-group></article-categories><title-group><article-title>Сепсис в педиатрической практике – пора договариваться</article-title><trans-title-group xml:lang="en"><trans-title>Pediatric sepsis – time to reach agreement</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0798-1625</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лекманов</surname><given-names>А. У.</given-names></name><name name-style="western" xml:lang="en"><surname>Lekmanov</surname><given-names>A. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лекманов Андрей Устинович д.м.н., проф., гл. науч. сотр. отдела хирургии детского возраста</p><p>450008 Уфа, ул. Ленина, д. 3</p></bio><email xlink:type="simple">aulek@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9016-9461</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронов</surname><given-names>П. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironov</surname><given-names>P. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронов Петр Иванович – д.м.н., проф. кафедры детской хирургии</p><p>450008 Уфа, ул. Ленина, д. 3</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт клинической хирургии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России; ГБУЗ города Москвы «Детская городская клиническая больница №9 им. Г.Н. Сперанского» ДЗМ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University; Speranskiy Children’s City Clinical Hospital No.9</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>08</day><month>07</month><year>2020</year></pub-date><volume>65</volume><issue>3</issue><fpage>131</fpage><lpage>137</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1161">https://www.ped-perinatology.ru/jour/article/view/1161</self-uri><abstract><p>Цель: представить эволюцию и современную концепцию сепсиса у детей.</p><p>По данным многих авторов, сепсис у детей считается основной причиной смерти от инфекционных заболеваний, причем смертность связана с задержкой диагностики и несоблюдением руководящих принципов терапии. В статье обсуждается эволюция взглядов на сепсис в течение последних 30 лет. Проанализированы изменения дефиниций сепсиса у взрослых от концепций Сепсис-1 к Сепсис-3. В настоящее время сепсис правильнее рассматривать не как прогрессирующее системное воспаление, а как угрожающую жизни органную дисфункцию вследствие дисрегуляции ответа организма на инфекцию. Так как в основе сепсиса лежит единый патобиологический процесс, определения сепсиса должны быть применимы одинаково к взрослым и детям. Однако терминология и интенсивная терапия педиатрического сепсиса находится вне рекомендаций Сепсис-3. В последние 3 года проведены исследования по использованию различных педиатрических шкал для верификации сепсиса и внедрения в педиатрию идеологии Сепсис-3. В настоящее время крайне важен консенсусный и мультидисциплинарный подход педиатров и врачей интенсивной терапии для достижения реальных успехов в ранней диагностике и снижении летальности при сепсисе у детей.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to present the evolution and modern concept of pediatric sepsis.</p><p>According to many authors, pediatric sepsis is considered to be the main cause of death from infectious diseases; and the mortality is associated with a late diagnosis and non-compliance with treatment guidelines. The article discusses the evolution of views on sepsis over the past 30 years. It analyzes the changes of sepsis concepts in adults from Sepsis-1 to Sepsis-3. Currently, sepsis is considered as a life-threatening organ dysfunction due to dysregulation of the body’s response to infection rather than a progressive systemic inflammation. Since sepsis is based on a pathobiological process, its definitions should be applied both to adults and children. However, the terminology and intensive care of pediatric sepsis is beyond the recommendations of Sepsis-3. Over the last 3 years the scientists have studied various pediatric scales to verify sepsis and introduce the Sepsis-3 ideology into pediatrics. Currently, the consensus and multidisciplinary approach of pediatricians and intensive care physicians is extremely important to achieve real success in early diagnosis and reduce mortality in children with sepsis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>сепсис</kwd><kwd>диагностика</kwd><kwd>оценка тяжести состояния</kwd></kwd-group><kwd-group xml:lang="en"><kwd>sepsis</kwd><kwd>children</kwd><kwd>diagnostics</kwd><kwd>assessment of the severity of the state</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rudd K.E., Johnson S.C., Agesa K.M., Shackelford K.A., Tsoi D., Kievlan D.R. et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395: 200–211. DOI: 10.1016/ S0140-6736(19)32989-7</mixed-citation><mixed-citation xml:lang="en">Rudd K.E., Johnson S.C., Agesa K.M., Shackelford K.A., Tsoi D., Kievlan D.R. et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395: 200–211. DOI: 10.1016/ S0140-6736(19)32989-7</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6): 1644–1655.</mixed-citation><mixed-citation xml:lang="en">Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6): 1644–1655.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vincent J.L., Martin G., Levy M. qSOFA does not replace SIRS in the definition of sepsis. Critical Care 2016; 20(1): 210. DOI 10.1186/s13054-016-1389</mixed-citation><mixed-citation xml:lang="en">Vincent J.L., Martin G., Levy M. qSOFA does not replace SIRS in the definition of sepsis. Critical Care 2016; 20(1): 210. DOI 10.1186/s13054-016-1389</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sprung C.L., Sakr Y., Vincent J.L., Le Gall J.R., Reinhart K., Ranieri V.M. et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study. Intensive Care Med 2006; 32: 421–427. DOI: 10.1007/s00134-005-0039-8</mixed-citation><mixed-citation xml:lang="en">Sprung C.L., Sakr Y., Vincent J.L., Le Gall J.R., Reinhart K., Ranieri V.M. et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study. Intensive Care Med 2006; 32: 421–427. DOI: 10.1007/s00134-005-0039-8</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dulhunty J.M., Lipman J., Finfer S. Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study. Intensive Care Med 2008; 34(9): 1654–1661. DOI: 10.1007/s00134-008-1160-2.2008;34:1654–61</mixed-citation><mixed-citation xml:lang="en">Dulhunty J.M., Lipman J., Finfer S. Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study. Intensive Care Med 2008; 34(9): 1654–1661. DOI: 10.1007/s00134-008-1160-2.2008;34:1654–61</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Churpek M.M., Zadravecz F.J., Winslow C., Howell M.D., Edelson D.P. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients Am J Respir Crit Care Med 2015; 192: 958–964. DOI: 10.1164/rccm.201502-0275OC</mixed-citation><mixed-citation xml:lang="en">Churpek M.M., Zadravecz F.J., Winslow C., Howell M.D., Edelson D.P. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients Am J Respir Crit Care Med 2015; 192: 958–964. DOI: 10.1164/rccm.201502-0275OC</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis‑3). JAMA 2016; 315: 801–810. DOI:10.1001/jama.2016.0287</mixed-citation><mixed-citation xml:lang="en">Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis‑3). JAMA 2016; 315: 801–810. DOI:10.1001/jama.2016.0287</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstein B., Giroir B., Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6(01): 2–8. DOI: 10.1097/01.PCC.0000149131.72248.E6</mixed-citation><mixed-citation xml:lang="en">Goldstein B., Giroir B., Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6(01): 2–8. DOI: 10.1097/01.PCC.0000149131.72248.E6</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Raymond S.L., Lopez M.C., Baker H.V., Larson S.D., Efron P.A., Sweeney T.E. et al. Unique transcriptomic response to sepsis is observed among patients of different age groups. PLoS ONE 2017; 12(9): e0184159. DOI: 10.1371/journal.pone.0184159</mixed-citation><mixed-citation xml:lang="en">Raymond S.L., Lopez M.C., Baker H.V., Larson S.D., Efron P.A., Sweeney T.E. et al. Unique transcriptomic response to sepsis is observed among patients of different age groups. PLoS ONE 2017; 12(9): e0184159. DOI: 10.1371/journal.pone.0184159</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">de Souza D.C., Machado F.R. Epidemiology of Pediatric Septic Shock. J Pediatr Intensive Care 2019; 8(1): 3–10. DOI: 10.1055/s-0038-1676634</mixed-citation><mixed-citation xml:lang="en">de Souza D.C., Machado F.R. Epidemiology of Pediatric Septic Shock. J Pediatr Intensive Care 2019; 8(1): 3–10. DOI: 10.1055/s-0038-1676634</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Scott H.F., Deakyne S.J., Woods J.M., Bajaj L. The prevalence and diagnostic utility of systemic inflammatory response syndrome vital signs in a pediatric emergency department. Acad Emerg Med 2015; 22: 381–389. DOI: 10,1111 / acem.12610</mixed-citation><mixed-citation xml:lang="en">Scott H.F., Deakyne S.J., Woods J.M., Bajaj L. The prevalence and diagnostic utility of systemic inflammatory response syndrome vital signs in a pediatric emergency department. Acad Emerg Med 2015; 22: 381–389. DOI: 10,1111 / acem.12610</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Agyeman P.K., Schlapbach L.J., Giannoni E., Stocker M., Posfay-Barbe K., Heininger U. et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Health 2017; 1: 124–133. DOI: 10.1016/S2352-4642(17)30010-X</mixed-citation><mixed-citation xml:lang="en">Agyeman P.K., Schlapbach L.J., Giannoni E., Stocker M., Posfay-Barbe K., Heininger U. et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Health 2017; 1: 124–133. DOI: 10.1016/S2352-4642(17)30010-X</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Schlapbach L.J., Straney L., Bellomo R., MacLaren G., Pilcher D. Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit. Int Care Med 2018; 44: 179–188. DOI: 10.1007/s00134-017-5021-8</mixed-citation><mixed-citation xml:lang="en">Schlapbach L.J., Straney L., Bellomo R., MacLaren G., Pilcher D. Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit. Int Care Med 2018; 44: 179–188. DOI: 10.1007/s00134-017-5021-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Schlapbach L. J., Kissoon N. Defining pediatric sepsis. JAMA Pediatr 2018; 172: 312–314. DOI: 10.1001 / jamapediatrics.2017.5208</mixed-citation><mixed-citation xml:lang="en">Schlapbach L. J., Kissoon N. Defining pediatric sepsis. JAMA Pediatr 2018; 172: 312–314. DOI: 10.1001 / jamapediatrics.2017.5208</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Davis A.L.; Carcillo J.A., Aneja R.K., Deymann A.J., Lin J.C., Nguyen T.C. et al. American College of Critical Care Medicine Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2017; 45: 1061–1093. DOI: 10.1097/CCM.00do00000000002425</mixed-citation><mixed-citation xml:lang="en">Davis A.L.; Carcillo J.A., Aneja R.K., Deymann A.J., Lin J.C., Nguyen T.C. et al. American College of Critical Care Medicine Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2017; 45: 1061–1093. DOI: 10.1097/CCM.00do00000000002425</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Balamuth F., Weiss S.L., Neuman M.I., Scott H., Brady P.W., Paul R. et al. Pediatric severe sepsis in U.S. children’s hospitals. Pediatr Crit Care Med 2014; 15(09): 798–805. DOI: 10.1097/PCC.0000000000000225</mixed-citation><mixed-citation xml:lang="en">Balamuth F., Weiss S.L., Neuman M.I., Scott H., Brady P.W., Paul R. et al. Pediatric severe sepsis in U.S. children’s hospitals. Pediatr Crit Care Med 2014; 15(09): 798–805. DOI: 10.1097/PCC.0000000000000225</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss S.L., Fitzgerald J.C., Pappachan J., Wheeler D., Jaramillo- Bustamante J.C., Salloo A. et al. Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015; 191(10): 1147–115. DOI: 10.1164 / rccm.201412-2323OC</mixed-citation><mixed-citation xml:lang="en">Weiss S.L., Fitzgerald J.C., Pappachan J., Wheeler D., Jaramillo- Bustamante J.C., Salloo A. et al. Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015; 191(10): 1147–115. DOI: 10.1164 / rccm.201412-2323OC</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Killien E.Y., Farris R.W.D., Watson R.S., Dervan L.A., Zimmerman J.J. Health-Related Quality of Life Among Survivors of Pediatric Sepsis. Pediatr Crit Care Med 2019; 20: 501–509. DOI: 10.1097/PCC.0000000000001886</mixed-citation><mixed-citation xml:lang="en">Killien E.Y., Farris R.W.D., Watson R.S., Dervan L.A., Zimmerman J.J. Health-Related Quality of Life Among Survivors of Pediatric Sepsis. Pediatr Crit Care Med 2019; 20: 501–509. DOI: 10.1097/PCC.0000000000001886</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Boeddha N., Schlapbach N., Driessen G., Herberg J., Rivero- Calle I., Cebey-López M. Mortality and morbidity in community- acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Critical Care 2018; 22: 143. DOI: 10.1186/s13054-018-2052-7</mixed-citation><mixed-citation xml:lang="en">Boeddha N., Schlapbach N., Driessen G., Herberg J., Rivero- Calle I., Cebey-López M. Mortality and morbidity in community- acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Critical Care 2018; 22: 143. DOI: 10.1186/s13054-018-2052-7</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Leclerc F., Duhamel A., Deken V., Grandbastien B., Leteurtre S., Biarent D. et al. Can the pediatric logistic organ dysfunction- 2 score on day 1 be used in clinical criteria for sepsis in children? Pediatr Crit Care Med 2017; 18: 758–763. DOI: 10.1097/PCC.0000000000001182</mixed-citation><mixed-citation xml:lang="en">Leclerc F., Duhamel A., Deken V., Grandbastien B., Leteurtre S., Biarent D. et al. Can the pediatric logistic organ dysfunction- 2 score on day 1 be used in clinical criteria for sepsis in children? Pediatr Crit Care Med 2017; 18: 758–763. DOI: 10.1097/PCC.0000000000001182</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Matics T.J., Pinto N.P., Sanchez-Pinto L.N. Association of Organ Dysfunction Scoresand Functional Outcomes Following Pediatric Critical Illness. Pediatr Crit Care Med 2019; 20: 722–727. DOI: 10.1097/PCC.0000000000001999</mixed-citation><mixed-citation xml:lang="en">Matics T.J., Pinto N.P., Sanchez-Pinto L.N. Association of Organ Dysfunction Scoresand Functional Outcomes Following Pediatric Critical Illness. Pediatr Crit Care Med 2019; 20: 722–727. DOI: 10.1097/PCC.0000000000001999</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Dewi R., Somasetia D.H., Risan N.A. Procalcitonin, C-Reactive Protein and its Correlation with Severity Based on Pediatric Logistic OrganDysfunction-2 (PELOD-2) Score in Pediatric Sepsis. Am J Epidemiol Infect Dis 2016; 4(3): 64–67. DOI: 10.12691/ajeid-4-3-3</mixed-citation><mixed-citation xml:lang="en">Dewi R., Somasetia D.H., Risan N.A. Procalcitonin, C-Reactive Protein and its Correlation with Severity Based on Pediatric Logistic OrganDysfunction-2 (PELOD-2) Score in Pediatric Sepsis. Am J Epidemiol Infect Dis 2016; 4(3): 64–67. DOI: 10.12691/ajeid-4-3-3</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Scott H.F., Brou L., Deakyne S.J., Kempe A., Fairclough D.L., Bajaj L. Association between early lactate levels and 30-day mortality in clinically suspected sepsis in children. JAMA Pediatr 2017; 171(3): 249–255. DOI: 10,1001 / jamapediatrics.2017.1598</mixed-citation><mixed-citation xml:lang="en">Scott H.F., Brou L., Deakyne S.J., Kempe A., Fairclough D.L., Bajaj L. Association between early lactate levels and 30-day mortality in clinically suspected sepsis in children. JAMA Pediatr 2017; 171(3): 249–255. DOI: 10,1001 / jamapediatrics.2017.1598</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Лекманов А.У., Миронов П.И., Руднов В.А., Кулабухов В.В. Современные дефиниции и принципы интенсивной терапии сепсиса у детей. Вестник анестезиологии и реаниматологии 2018; 15(4): 60-68. DOI: 10.21292/2078-5658-2018-15-4-61-69</mixed-citation><mixed-citation xml:lang="en">Lekmanov A.U., Mironov P.I., Rudnov V.A., Kulabuhov V.V. Modern definitions and principles of intensive care for sepsis in children. Vestnik anesteziologii i reanimatologii 2018; 15(4): 60–68. (in Russ.) DOI: 10.21292/2078-5658-2018-15-4-61-69</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
